Patients with a cancer of the lining of the lung, known as malignant pleural mesothelioma (MPM), lived longer than previously reported(1), when treated with Eli Lilly and Company's Alimta(®) (pemetrexed) in combination with cisplatin, according to updated data presented at the 11th annual Conference on Lung Cancer (WCLC).Mature data presented at WCLC represent an update from trial results from